Client Overview
A Korea-based biotechnology manufacturer required Regulatory support for the preparation of a Common Technical Document (CTD) and submission of a Biologics License Application (BLA). The client also sought assistance with the strategic registration of its biological product in LATAM and APAC markets.
Background
The client was preparing to submit a BLA in the United States and expand its product presence across multiple international markets. To support these objectives, the client required expertise in CTD preparation, Regulatory strategy development, and country-specific registration planning to ensure successful submissions and approvals across LATAM and APAC regions.
Services in Scope
CTD preparation and review
BLA submission support
Regulatory strategy development
CMC data assessment and gap analysis
Product registration support in LATAM and APAC markets
Country-specific dossier planning and submission strategy
Regulatory submission coordination and execution
Challenge
The client faced challenges in developing an effective Regulatory strategy and obtaining submission support for registering its biological product across LATAM and APAC markets.
In addition, the client required support in assessing and generating data aligned with U.S. FDA requirements.
Identifying data gaps and ensuring the availability of adequate information for submission presented a significant challenge in preparing a compliant BLA dossier and supporting global registration activities.
Solution
1
Freyr provided comprehensive Regulatory support throughout the BLA preparation and global registration process.
2
The team conducted a detailed assessment of the Chemistry, Manufacturing, and Controls (CMC) data provided by the client and performed a gap analysis to identify additional data requirements necessary to meet U.S. FDA expectations.
3
Freyr also supported the preparation of the CTD and BLA submission package while developing a Regulatory submission strategy tailored to the client's target markets.
4
Country-specific dossier checklists were prepared to facilitate smooth submissions across LATAM and APAC countries and to help avoid pre-submission assessment delays.
5
Based on the agreed Regulatory strategy, Freyr coordinated and executed product registration activities across the targeted markets, ensuring submissions were completed within the stipulated timelines.
Impact
Freyr successfully supported the Korea-based biotechnology manufacturer in the preparation and submission of its Biologics License Application (BLA) while facilitating strategic product registration across LATAM and APAC markets. Through comprehensive Regulatory planning, dossier preparation, gap assessment, and country-specific submission strategies, Freyr enabled efficient execution of the project and supported the client's global market expansion objectives.
Successfully supported BLA submission in the United States
Product registration dossiers submitted in multiple targeted LATAM and APAC countries
Ensured compliance through comprehensive CMC data assessment and gap analysis
Facilitated timely dossier submissions through country-specific Regulatory strategies
Successfully executed the project within agreed timelines
